CLATTERBRIDGE Cancer Charity welcomed its new board of trustees.

Heading up the Charity’s first ever Board of Trustees is Brian Barwick OBE, who joins as chair.

Brian was Head of Sport for the BBC and ITV, Chief Executive Officer of the FA and subsequently chair of the RFL. In 2021, he was awarded an OBE in the Queen’s New Year Honours list for services to sport and sport broadcasting. He is a native of Liverpool and alumnus of the University of Liverpool, where he returned as a visiting professor. He was Chair of the UCFB Advisory Board and is currently a member of Liverpool Hope University’s Business School. Brian is a respected media contributor and a published author with a great regard and love for the city.

Chair Brian Barwick OBE, said: “I am a proud son of Liverpool and I am honoured to become Clatterbridge Cancer Charity’s very first Chair of Trustees.

“This is a great opportunity to give back to the people of Merseyside and Cheshire and I am delighted to bring my experience and support to this special Charity.”

Joining him as Trustees are; Cathy Frost, owner and CEO of Liverpool’s Panoramic 34 restaurant, who is also a patron of the charity, Savvas Neophytou, a specialist in technology and healthcare investments, corporate financier Stephen Stuart, Prof Philip Wilson, an experienced leader in higher education across multiple countries and award-winning local entrepreneur Jordan Wright. They are joined by Kathy Doran who is also the chair of The Clatterbridge Cancer Centre NHS Foundation Trust along with the trust’s medical director Dr Sheena Khanduri.

Clatterbridge Cancer Charity’s Chief Executive Katrina Bury said: “I am absolutely delighted to have Brian Barwick OBE join the Charity as Chair and would like to welcome our first Board of Trustees.

“I am thrilled to have such a dedicated and passionate team on board and would like to say thank you to each of them for volunteering their time to help take the Charity on the next stage of its development, ensuring we will continue to help local people with cancer well into the future.”